167 related articles for article (PubMed ID: 2310276)
1. Population-based frequency of dyslipidemia syndromes in coronary-prone families in Utah.
Williams RR; Hopkins PN; Hunt SC; Wu LL; Hasstedt SJ; Lalouel JM; Ash KO; Stults BM; Kuida H
Arch Intern Med; 1990 Mar; 150(3):582-8. PubMed ID: 2310276
[TBL] [Abstract][Full Text] [Related]
2. Concordant dyslipidemia, hypertension and early coronary disease in Utah families.
Williams RR; Hunt SC; Wu LL; Hopkins PN; Hasstedt SJ; Schumacher MC; Stults BM; Kuida H
Klin Wochenschr; 1990; 68 Suppl 20():53-9. PubMed ID: 2189041
[TBL] [Abstract][Full Text] [Related]
3. A long-term follow-up study of serum lipid levels and coronary heart disease in the elderly.
Li JZ; Chen ML; Wang S; Dong J; Zeng P; Hou LW
Chin Med J (Engl); 2004 Feb; 117(2):163-7. PubMed ID: 14975195
[TBL] [Abstract][Full Text] [Related]
4. Segregation analysis of HDL cholesterol in the NHLBI Family Heart Study and in Utah pedigrees.
Kronenberg F; Coon H; Ellison RC; Borecki I; Arnett DK; Province MA; Eckfeldt JH; Hopkins PN; Hunt SC
Eur J Hum Genet; 2002 Jun; 10(6):367-74. PubMed ID: 12080388
[TBL] [Abstract][Full Text] [Related]
5. Coronary risk factors in adolescents related to their knowledge of familial coronary heart disease and hypercholesterolemia: the Muscatine Study.
Muhonen LE; Burns TL; Nelson RP; Lauer RM
Pediatrics; 1994 Mar; 93(3):444-51. PubMed ID: 8115204
[TBL] [Abstract][Full Text] [Related]
6. Lability of serum low-density lipoprotein cholesterol levels during screening in subgroup of Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS) cohort.
Clearfield MB; Weis SE; Willis JM; Vasenius KA; McConathy WJ
J Am Osteopath Assoc; 2002 Jul; 102(7):377-84. PubMed ID: 12138952
[TBL] [Abstract][Full Text] [Related]
7. Risk determination of dyslipidemia in populations characterized by low levels of high-density lipoprotein cholesterol.
Bersot TP; Pépin GM; Mahley RW
Am Heart J; 2003 Dec; 146(6):1052-9. PubMed ID: 14660998
[TBL] [Abstract][Full Text] [Related]
8. Plasma triglycerides and type III hyperlipidemia are independently associated with premature familial coronary artery disease.
Hopkins PN; Wu LL; Hunt SC; Brinton EA
J Am Coll Cardiol; 2005 Apr; 45(7):1003-12. PubMed ID: 15808755
[TBL] [Abstract][Full Text] [Related]
9. Family history fails to identify many children with severe hypercholesterolemia.
Starc TJ; Belamarich PF; Shea S; Dobrin-Seckler BE; Dell RB; Gersony WM; Deckelbaum RJ
Am J Dis Child; 1991 Jan; 145(1):61-4. PubMed ID: 1985431
[TBL] [Abstract][Full Text] [Related]
10. Metabolic factors clustering, lipoprotein cholesterol, apolipoprotein B, lipoprotein (a) and apolipoprotein E phenotypes in premature coronary artery disease in French Canadians.
Weber M; McNicoll S; Marcil M; Connelly P; Lussier-Cacan S; Davignon J; Latour Y; Genest J
Can J Cardiol; 1997 Mar; 13(3):253-60. PubMed ID: 9117913
[TBL] [Abstract][Full Text] [Related]
11. Apparent protective effect of high density lipoprotein against coronary heart disease in the elderly.
Li JZ; Chen ML; Wang S; Dong J; Zeng P; Hou LW
Chin Med J (Engl); 2004 Apr; 117(4):511-5. PubMed ID: 15109440
[TBL] [Abstract][Full Text] [Related]
12. Coronary artery disease risk in familial combined hyperlipidemia and familial hypertriglyceridemia: a case-control comparison from the National Heart, Lung, and Blood Institute Family Heart Study.
Hopkins PN; Heiss G; Ellison RC; Province MA; Pankow JS; Eckfeldt JH; Hunt SC
Circulation; 2003 Aug; 108(5):519-23. PubMed ID: 12847072
[TBL] [Abstract][Full Text] [Related]
13. Prevalence of high plasma triglyceride combined with low HDL-C levels and its association with smoking, hypertension, obesity, diabetes, sedentariness and LDL-C levels in the Canadian population. Canadian Heart Health Surveys Research Group.
Connelly PW; Petrasovits A; Stachenko S; MacLean DR; Little JA; Chockalingam A
Can J Cardiol; 1999 Apr; 15(4):428-33. PubMed ID: 10322252
[TBL] [Abstract][Full Text] [Related]
14. Raising high-density lipoprotein cholesterol with reduction of cardiovascular risk: the role of nicotinic acid--a position paper developed by the European Consensus Panel on HDL-C.
Chapman MJ; Assmann G; Fruchart JC; Shepherd J; Sirtori C;
Curr Med Res Opin; 2004 Aug; 20(8):1253-68. PubMed ID: 15324528
[TBL] [Abstract][Full Text] [Related]
15. Nomogram to diagnose familial combined hyperlipidemia on the basis of results of a 5-year follow-up study.
Veerkamp MJ; de Graaf J; Hendriks JC; Demacker PN; Stalenhoef AF
Circulation; 2004 Jun; 109(24):2980-5. PubMed ID: 15184285
[TBL] [Abstract][Full Text] [Related]
16. Evidence for gene-environmental interactions in Utah families with hypertension, dyslipidaemia and early coronary heart disease.
Williams RR; Hunt SC; Hopkins PN; Wu LL; Schumacher MC; Stults BM; Ball L; Ware J; Hasstedt SJ; Lalouel JM
Clin Exp Pharmacol Physiol Suppl; 1992; 20():1-6. PubMed ID: 1446402
[TBL] [Abstract][Full Text] [Related]
17. [Fuenlabrada study: lipid and lipoprotein levels in children and adolescents associated with ischemic cardiopathy prevalence among their relatives].
Plaza I; Mariscal RP; Muñoz MT; Ros-Jellici J; López D; Madero R; Hidalgo I; Ceñal MJ; Baeza J; Cobaleda A
Rev Esp Cardiol; 1990 Apr; 43(4):212-8. PubMed ID: 2353119
[TBL] [Abstract][Full Text] [Related]
18. Importance of HDL cholesterol levels and the total/ HDL cholesterol ratio as a risk factor for coronary heart disease in molecularly defined heterozygous familial hypercholesterolaemia.
Real JT; Chaves FJ; Martínez-Usó I; García-García AB; Ascaso JF; Carmena R
Eur Heart J; 2001 Mar; 22(6):465-71. PubMed ID: 11237541
[TBL] [Abstract][Full Text] [Related]
19. [Serum thromboxane B2 and prostaglandin F2 alpha in familial combined hyperlipoproteinemia and familial hypercholesterolemia].
Sziegoleit W; Wichmann T; Block HU; Taube C; Mest HJ
Wien Klin Wochenschr; 1991; 103(8):227-31. PubMed ID: 1858388
[TBL] [Abstract][Full Text] [Related]
20. Comparison of fluvastatin + fenofibrate combination therapy and fluvastatin monotherapy in the treatment of combined hyperlipidemia, type 2 diabetes mellitus, and coronary heart disease: a 12-month, randomized, double-blind, controlled trial.
Derosa G; Cicero AE; Bertone G; Piccinni MN; Ciccarelli L; Roggeri DE
Clin Ther; 2004 Oct; 26(10):1599-607. PubMed ID: 15598476
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
